U of Toronto creates school of public health with $20-million donation
UToronto calls new school Canada's largest network of public health and educators dedicated to disease prevention
“I would expect that this school will be one of the leading schools of public health in the world.”
Mandel, who specializes in the connection between certain cancers and environmental, occupational and lifestyle factors, conducted the first randomized controlled clinical trial to show the benefit of colorectal cancer screening in reducing both the number of cases and deaths from the disease.
“We have the technology that will not only allow us to reduce the mortality from colorectal cancer, but actually reduce the incidence of disease,” he said. “And we’re only now beginning to apply that technology across the country here. It’s slow.”
The same could be said about public health promotion in general, Mandel noted.
“There’s a lot we know about preventing illness or premature death. There’s a great deal we know. But all of it is not being applied as well as it could be.”
-with a report from CP
page 1 page 2
